Challenges in Chronic Genetic Disorders: Lessons From the COVID-19 Pandemic

Indian Pediatr. 2021 Apr 15;58(4):391-392. doi: 10.1007/s13312-021-2202-x.

Abstract

To examine the impact of the COVID-19 pandemic, we interviewed 26 patients with lysosomal storage disorders receiving enzyme replacement therapy. 20 (77 %) had significant interruption in their treatment, with an average of 8 (range 2-28) missed doses. Alternate methods of delivering uninterrupted care including home therapy were used. Vulnerable patients with chronic genetic disorders require organization for their multidisciplinary needs of care.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Civil Defense / standards
  • Enzyme Replacement Therapy / methods*
  • Female
  • Genetic Diseases, Inborn / epidemiology
  • Genetic Diseases, Inborn / therapy
  • Health Services Accessibility* / organization & administration
  • Health Services Accessibility* / standards
  • Health Services Needs and Demand
  • Humans
  • India / epidemiology
  • Infection Control
  • Lysosomal Storage Diseases* / epidemiology
  • Lysosomal Storage Diseases* / therapy
  • Male
  • Medication Therapy Management* / organization & administration
  • Medication Therapy Management* / standards
  • SARS-CoV-2
  • Surveys and Questionnaires